https://www.urologytimes.com/view/sipuleucel-t-an-innovative-immunotherapy-option-for-metastatic-castration-resistant-prostate-cancer
Sipuleucel-T: An innovative immunotherapy option for metastatic castration-resistant prostate...
Oct 9, 2026 - In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Kelvin A. Moses, MD, PhD, discusses the prostate cancer immunotherapy...
sipuleucelinnovativeimmunotherapyoptionmetastatic